These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 29412346)

  • 21. Community-Oriented Epidemic Preparedness and Response to the Jerusalem 2018-2019 Measles Epidemic.
    Stein-Zamir C; Abramson N; Edelstein N; Shoob H; Zentner G; Zimmerman DR
    Am J Public Health; 2019 Dec; 109(12):1714-1716. PubMed ID: 31622151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of a measles outbreak in Granada with preventive measures applied by the courts, Spain, 2010 to 2011.
    Navarro E; Mochón MM; Galicia MD; Marín I; Laguna J
    Euro Surveill; 2013 Oct; 18(43):. PubMed ID: 24176617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in implementing measles mortality reduction strategies--India, 2010-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Sep; 60(38):1315-9. PubMed ID: 21956408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of the vaccination campaign on hospitalization and mortality linked to measles in Brazil in the last decade].
    Loureiro AAR; Dutra HF; Gonçalves EBD; Pereira FOS; Argolo BM; Fonseca RMD; Fófano GA
    Cien Saude Colet; 2024 May; 29(5):e20042022. PubMed ID: 38747780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles eradication in the Americas: experience in Haiti.
    Venczel L; Dobbins J; André J; Laender F; Izurieta H; Delorme P; Voltaire HC
    J Infect Dis; 2003 May; 187 Suppl 1():S127-32. PubMed ID: 12721903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Madagascar 2018-2019 measles outbreak response: main strategic areas.
    Sodjinou VD; Douba A; Nimpa MM; Masembe YV; Randria M; Ndiaye CF
    Pan Afr Med J; 2020; 37():20. PubMed ID: 33062122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of epidemiological characteristics of measles in Beijing before and after supplementary immunization campaigns of measles vaccine in 2010].
    Ma R; Lu L; Zhang Z; Suo L; Li J; Chen M; Yu X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1036-41. PubMed ID: 26887295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles outbreaks in Australia: obstacles to vaccination.
    Dawson B; Apte SH
    Aust N Z J Public Health; 2015 Apr; 39(2):104-6. PubMed ID: 25715740
    [No Abstract]   [Full Text] [Related]  

  • 29. Measles vaccination in an increasingly immunized and developed world.
    Hayman DTS
    Hum Vaccin Immunother; 2019; 15(1):28-33. PubMed ID: 30156949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province, Democratic Republic of Congo.
    Keating P; Carrion Martin AI; Blake A; Lechevalier P; Uzzeni F; Gignoux E; Okonta C; Langendorf C; Smit S; Ahuka S; Suchard M; Pukuta E; Degail MA; Hansen L; Kibanza-Kyungu J; Ciglenecki I; Cohuet S
    BMC Public Health; 2019 Aug; 19(1):1153. PubMed ID: 31438898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles outbreak investigation in Ginnir district of Bale zone, Oromia region, Southeast Ethiopia, May 2019.
    Kalil FS; Gemeda DH; Bedaso MH; Wario SK
    Pan Afr Med J; 2020; 36():20. PubMed ID: 32774597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges to Achieving Measles Elimination, Georgia, 2013-2018.
    Khetsuriani N; Sanadze K; Chlikadze R; Chitadze N; Dolakidze T; Komakhidze T; Jabidze L; Huseynov S; Ben Mamou M; Muller C; Zakhashvili K; Hübschen JM
    Emerg Infect Dis; 2020 Nov; 26(11):2565-2577. PubMed ID: 33079037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles outbreak response vaccination in the Federated States of Micronesia.
    Gopalani SV; Helgenberger L; Apaisam C; Donre S; Takiri K; Charley J; Yomai A; Judicpa P; Nakazono N; Johnson E; Setik E; Taulung L; Elias A; Barrow-Kohler L
    Int J Epidemiol; 2016 Oct; 45(5):1394-1400. PubMed ID: 27272184
    [No Abstract]   [Full Text] [Related]  

  • 34. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
    Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
    Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Measles epidemiology in the State of Santa Catarina, Brazil, 1996-2000].
    Faversani MC; Kupek E; Westrupp MH
    Cad Saude Publica; 2005; 21(2):535-44. PubMed ID: 15905916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socio-demographic correlates of first dose of measles (MCV1) vaccination coverage in India.
    Panda BK; Mishra S; Awofeso N
    BMC Public Health; 2020 Aug; 20(1):1221. PubMed ID: 32778085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles eradication: experience in the Americas.
    de Quadros CA; Hersh BS; Nogueira AC; Carrasco PA; da Silveira CM
    Bull World Health Organ; 1998; 76 Suppl 2(Suppl 2):47-52. PubMed ID: 10063674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in measles control--Kenya 2002-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(37):969-72. PubMed ID: 17882128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated measles control--Cambodia, 1999-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Jan; 52(1):4-6. PubMed ID: 12549899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.